Archives of Pediatric Infectious Diseases

Published by: Kowsar

The Frequency of Shiga Toxin Producing Escherichia coli in Patients with Urinary Tract Infection in Iran: Systematic Review and Meta-Analysis

Nakysa Hooman 1 , * , Amjad Ahmadi 2 , Shahrbanoo Nakhaie 3 , Rama Nagh Shizadian 4 and Mohsen Yaghoubi 5
Authors Information
1 Department of Pedaitric Nephrology, Ali-Asghar Clinical Research Development Center, Iran University of Medical Sciences, Tehran, Iran
2 Department of Microbiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
3 Department of Pediatric Gastroenterology, Ali-Asghar Clinical Research Development Center, Iran University of Medical Sciences, Tehran, IR Iran
4 Department of Pediatrics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
5 School of Public Health, University of Saskatchewan, Saskatoon, Canada
Article information
  • Archives of Pediatric Infectious Diseases: July 2018, 6 (3); e78816
  • Published Online: June 25, 2018
  • Article Type: Review Article
  • Received: May 17, 2018
  • Accepted: May 19, 2018
  • DOI: 10.5812/pedinfect.78816

To Cite: Hooman N, Ahmadi A, Nakhaie S, Nagh Shizadian R, Yaghoubi M. The Frequency of Shiga Toxin Producing Escherichia coli in Patients with Urinary Tract Infection in Iran: Systematic Review and Meta-Analysis, Arch Pediatr Infect Dis. 2018 ; 6(3):e78816. doi: 10.5812/pedinfect.78816.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Nateghian AR, Robinson JL, Mohandessi S, Hooman N. Resistance pattern of breakthrough urinary tract infections in children on antibiotic prophylaxis. J Infect Public Health. 2009;2(3):147-52. doi: 10.1016/j.jiph.2009.08.002. [PubMed: 20701875].
  • 2. Hooman N. Acute Kidney Injury in Iranian Children -What Do We Know About It? J Ped Nephrol. 2014;2(3):98-103.
  • 3. Otukesh H, Hoseini R, Golnari P, Fereshtehnejad SM, Zamanfar D, Hooman N, et al. Short-term and long-term outcome of hemolytic uremic syndrome in Iranian children. J Nephrol. 2008;21(5):694-703. [PubMed: 18949724].
  • 4. Mohkam M. Kidney Ultrasonography and Dimercaptosuccinic Acid Scans for Revealing Vesicoureteral Reflux in Children With Pyelonephritis: A 7-Year Prospective Cohort Study of 1500 Pyelonephritic Patients and 2986 Renal Units. Nephro Urol Mon. 2011;4(1):350-5. doi: 10.5812/numonthly.1972.
  • 5. Sobouti B, Hooman N, Movahed M. The effect of vitamin E or vitamin A on the prevention of renal scarring in children with acute pyelonephritis. Pediatr Nephrol. 2012;28(2):277-83. doi: 10.1007/s00467-012-2308-4.
  • 6. Mohkam M, Maham S, Rahmani A, Naghi I, Otokesh B, Raiiati H, et al. Technetium Tc 99m dimercaptosuccinic acid renal scintigraphy in children with acute pyelonephritis: correlation with other imaging tests. Iran J Kidney Dis. 2010;4(4):297-301. [PubMed: 20852370].
  • 7. Hooman N, Isa-Tafreshi R, Mostafavi SH, Hallaji F, Tavasoli A, Otukesh H. The prevalence of hypertension in children with renal scars. Minerva Pediatr. 2017;69(3):200-5. doi: 10.23736/S0026-4946.16.04217-1. [PubMed: 28452212].
  • 8. Tullus K. Vesicoureteric reflux in children. Lancet. 2015;385(9965):371-9. doi: 10.1016/S0140-6736(14)60383-4. [PubMed: 25164069].
  • 9. Rahimzadeh N, Otukesh H, Hoseini R, Shadani S, Hooman N. Serum procalcitonin level for prediction of high-grade vesicoureteral reflux in urinary tract infection. Iran J Kidney Dis. 2014;8(2):105-8. [PubMed: 24685732].
  • 10. Hooman N. Validity and reliability of Persian translated version of Pediatric Lower Urinary Tract Scoring System Questionnaire for Iranian children. Med J Islam Repub Iran. 2013;27(3):147-52. [PubMed: 24791125]. [PubMed Central: PMC3917488].
  • 11. Mostafavi SH, Hooman N, Hallaji F, Emami M, Aghelnezhad R, Moradi-Lakeh M, et al. The correlation between bladder volume wall index and the pattern of uroflowmetry/external sphincter electromyography in children with lower urinary tract malfunction. J Pediatr Urol. 2012;8(4):367-74. doi: 10.1016/j.jpurol.2011.07.009. [PubMed: 21820964].
  • 12. Toval F, Kohler CD, Vogel U, Wagenlehner F, Mellmann A, Fruth A, et al. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection. J Clin Microbiol. 2014;52(2):407-18. doi: 10.1128/JCM.02069-13. [PubMed: 24478469]. [PubMed Central: PMC3911323].
  • 13. Toval F, Schiller R, Meisen I, Putze J, Kouzel IU, Zhang W, et al. Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli. Infect Immun. 2014;82(11):4631-42.
  • 14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7). e1000097.
  • 15. Hooman N, Mansour Ghanaei R, Yaghoubi M, Nakhaie S. The prevalence of Shiga toxin-producing Escherichia coli in patients with gastroenteritis and sources of infections in Iran: systematic review and meta-analysis. PROSPERO 2016 CRD42016033019. 2016. Available from:
  • 16. Hooman N, Mansour-Ghanaei R, Yaghoubi M, Nakhaie S. The Prevalence of Shiga toxin-producing Escherichia coli in Patients with Gastroenteritis and Sources of Infections in Iran: A Systematic Review Study Protocol. J Pediatr Nephrol. 2016;4(3):82-5.
  • 17. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495-9. doi: 10.1016/j.ijsu.2014.07.013. [PubMed: 25046131].
  • 18. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934-9. doi: 10.1016/j.jclinepi.2011.11.014. [PubMed: 22742910].
  • 19. Aghaee N. Detection of Shiga Toxin-Producing Strains of Escherichia coli (O157: H7) isolated from specimens of urinary and stool by Multiplex-PCR method. Yafteh. 2006;8(1):21-7.
  • 20. Abbasi K, Tajbakhsh E. Prevalence of Shiga toxin genes and intimin genes in uropathogenic Escherichia coli. J Coast Life Med. 2015;3(10):791-6. doi: 10.12980/jclm.3.2015j5-142.
  • 21. Mansouri F, Shams N, Rashidian E. Prevalence of Shiga Toxin-Producing Genes in Escherichia Coli Isolated From Patients with Urinary Tract Infections in Khorramabad. Med J Tabriz Univ Med Sci Health Serv. 2015;37(3):50-5.
  • 22. Adeli Z, Firoozeh F, Zibaei M, Shakib P. Prevalence of Shiga toxin and Intimine genes in Shiga toxin-producing Escherichia coli isolated from urine samples in Lorestan, Iran. KAUMS J. 2013;17(2):188-94.
  • 23. Nazemi A. Detection of stx1, stx2, LT and ST toxin genes and O157 and H7 antigen genes among uropathogenic Escherichia coli isolates from Iran. Afr J Microbiol Res. 2012;6(5). doi: 10.5897/ajmr-11-944.
  • 24. Navidinia M, Karimi A, Rahbar M, Fallah F, Ahsani RR, Malekan MA, et al. Study Prevalence of Verotoxigenic E.coli Isolated from Urinary Tract Infections (UTIs) in an Iranian Children Hospital. Open Microbiol J. 2012;6:1-4. doi: 10.2174/1874285801206010001. [PubMed: 22291863]. [PubMed Central: PMC3267085].
  • 25. Ardalan M. Urinary tract infection associated with thrombotic microangiopathy. Nephrourol Mon. 2014;6(1). e12478. doi: 10.5812/numonthly.12478. [PubMed: 24719813]. [PubMed Central: PMC3968997].
  • 26. Park YA, Schultz EF, Hay SN, Brecher ME. Thrombotic thrombocytopenic purpura and urinary tract infections: is there a connection? Am J Clin Pathol. 2011;135(1):85-8. doi: 10.1309/AJCPGM0SC6KOTCAN. [PubMed: 21173128].
  • 27. Miedouge M, Hacini J, Grimont F, Watine J. Shiga toxin-producing Escherichia coli urinary tract infection associated with hemolytic-uremic syndrome in an adult and possible adverse effect of ofloxacin therapy. Clin Infect Dis. 2000;30(2):395-6. doi: 10.1086/313668. [PubMed: 10671349].
  • 28. Miedouge M, Watine J, Hacini J, Grimont F. [A case of hemolytic-uremic syndrome associated with urinary infection caused by Escherichia coli producing verotoxin]. Ann Biol Clin (Paris). 1999;57(6):727-9. [PubMed: 10572225].
  • 29. Starr M, Bennett-Wood V, Bigham AK, de Koning-Ward TF, Bordun AM, Lightfoot D, et al. Hemolytic-uremic syndrome following urinary tract infection with enterohemorrhagic Escherichia coli: case report and review. Clin Infect Dis. 1998;27(2):310-5. [PubMed: 9709881].
  • 30. Hogan MC, Gloor JM, Uhl JR, Cockerill FR, Milliner DS. Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection. Am J Kidney Dis. 2001;38(4). E22. [PubMed: 11576909].
  • 31. Nguyen QV, Hochstrasser L, Chuard C, Hachler H, Regamey C, Descombes E. Adult hemolytic-uremic syndrome associated with urosepsis due to Shigatoxin-producing Escherichia coli O138:H. Ren Fail. 2007;29(6):747-50. doi: 10.1080/08860220701460418. [PubMed: 17763172].
  • 32. Chiurchiu C, Firrincieli A, Santostefano M, Fusaroli M, Remuzzi G, Ruggenenti P. Adult nondiarrhea hemolytic uremic syndrome associated with Shiga toxin Escherichia coli O157:H7 bacteremia and urinary tract infection. Am J Kidney Dis. 2003;41(1). E4. doi: 10.1053/ajkd.2003.50022. [PubMed: 12500215].
  • 33. Nguyen QV, Descombes E. Etiology-based classification of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. What about hemolytic uremic syndrome associated with urinary tract infections? Kidney Int. 2007;71(5):466. author reply 466. doi: 10.1038/ [PubMed: 17315009].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments